Voloridge Investment Management, LLC Syndax Pharmaceuticals Inc Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$18.51 - $24.79 $206,219 - $276,185
11,141 Added 106.9%
21,563 $518,000
Q2 2022

Aug 15, 2022
SELL
$13.64 - $19.48 $1.51 Million - $2.15 Million
-110,609 Reduced 91.39%
10,422 $201,000
Q1 2022

May 16, 2022
BUY
$14.84 - $22.15 $1.59 Million - $2.37 Million
107,202 Added 775.2%
121,031 $2.1 Million
Q4 2021

Feb 14, 2022
BUY
$15.23 - $22.47 $210,615 - $310,737
13,829 New
13,829 $303,000

Others Institutions Holding SNDX

# of Institutions
229
Shares Held
89.5M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $878M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email